Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.74%823.39B | 14.02%829.56B | 11.28%740.33B | 6.89%2.84T | 5.36%684.06B | 3.03%764.21B | 6.16%727.53B | 14.41%665.28B | 14.32%2.66T | 16.20%649.28B |
Cost of revenue | 13.45%358.01B | 20.13%362.18B | 22.02%320.1B | 12.37%1.23T | 21.82%346.6B | 5.68%315.56B | 9.00%301.48B | 13.43%262.33B | 14.02%1.09T | 14.62%284.51B |
Gross profit | 3.73%465.38B | 9.70%467.38B | 4.29%420.23B | 3.08%1.62T | -7.49%337.46B | 1.25%448.64B | 4.24%426.06B | 15.05%402.95B | 14.54%1.57T | 17.46%364.78B |
Operating expense | 13.77%265.78B | 14.15%252.46B | 4.37%206.49B | 3.23%951.03B | 2.10%298.41B | -6.32%233.61B | 6.87%221.16B | 14.58%197.84B | 5.54%921.28B | -0.13%292.29B |
Selling and administrative expenses | 9.38%270.56B | 15.48%261.86B | 5.75%212.86B | 4.20%981.05B | 1.32%305.66B | -1.99%247.35B | 6.86%226.77B | 14.83%201.28B | 5.96%941.54B | 1.22%301.68B |
-General and administrative expense | 9.38%270.56B | 15.48%261.86B | 5.75%212.86B | 4.20%981.05B | 1.32%305.66B | -1.99%247.35B | 6.86%226.77B | 14.83%201.28B | 5.96%941.54B | 1.22%301.68B |
Total other operating income | -65.19%4.78B | 67.65%9.4B | 85.43%6.38B | 48.19%30.03B | -22.88%7.24B | 359.38%13.74B | 6.48%5.61B | 31.46%3.44B | 29.70%20.26B | 75.27%9.39B |
Operating profit | -7.18%199.6B | 4.89%214.92B | 4.21%213.75B | 2.87%664.08B | -46.14%39.05B | 11.00%215.03B | 1.54%204.9B | 15.52%205.11B | 30.41%645.57B | 305.66%72.49B |
Net non-operating interest income (expenses) | -313.01%-22.77B | -12.87%-19.04B | 37.43%-14.55B | 15.50%-50.81B | 68.44%-5.17B | 74.66%-5.51B | 7.93%-16.87B | -533.91%-23.26B | -125.76%-60.13B | -67.88%-16.38B |
Non-operating interest income | 53.93%19.49B | 74.62%16.61B | 98.81%14.88B | 42.59%44.41B | 10.24%14.76B | 60.82%12.66B | 100.87%9.51B | 45.30%7.48B | 63.82%31.15B | 318.28%13.39B |
Non-operating interest expense | 132.53%42.26B | 35.13%35.65B | -4.27%29.43B | 4.33%95.22B | -33.05%19.93B | -38.67%18.17B | 14.42%26.38B | 248.58%30.74B | 99.96%91.27B | 129.73%29.77B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 34.06%4.37B | -14.72%1.92B | 59.58%2.07B | 4.03%8.33B | -12.91%1.52B | 23.31%3.26B | -19.67%2.26B | 59.19%1.3B | 100.38%8.01B | 283.08%1.74B |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -14.84%181.2B | 3.95%197.81B | 9.89%201.27B | 4.74%621.6B | -38.83%35.39B | 21.86%212.78B | 2.15%190.28B | 4.84%183.15B | 25.63%593.45B | 575.15%57.85B |
Income tax | -22.79%43.78B | 2.98%48.45B | 14.71%43.5B | -8.70%136.29B | -130.58%-5.39B | 58.92%56.71B | 2.53%47.05B | -24.31%37.92B | 12.91%149.28B | 103.08%17.61B |
Net income | -11.95%137.42B | 4.27%149.36B | 8.63%157.77B | 9.26%485.31B | 1.33%40.78B | 12.34%156.07B | 2.02%143.24B | 16.55%145.23B | 30.57%444.17B | 38,796.15%40.24B |
Net income continuous operations | -11.95%137.42B | 4.27%149.36B | 8.64%157.77B | 9.26%485.31B | 1.33%40.78B | 12.34%156.07B | 2.02%143.24B | 16.55%145.23B | 30.57%444.17B | 39,170.87%40.24B |
Noncontrolling interests | -83.61%175M | 59.50%1.45B | -7.56%501M | 107.20%3.02B | -62.55%500M | 230.72%1.07B | 103.35%911M | 10.16%542M | -13.78%1.46B | 509.59%1.34B |
Net income attributable to the company | -11.46%137.24B | 3.92%147.91B | 8.70%157.27B | 8.94%482.29B | 3.52%40.28B | 10.92%155B | 1.69%142.33B | 16.58%144.68B | 30.79%442.72B | 12,146.13%38.91B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0.00%1M | -1M | 1M | 0 | 0 | 0.00%1M | 0 | 0 | 0 |
Net income attributable to common stockholders | -11.46%137.24B | 3.92%147.91B | 8.70%157.27B | 8.94%482.29B | 3.52%40.28B | 10.92%155B | 1.69%142.33B | 16.58%144.68B | 30.79%442.72B | 12,146.13%38.91B |
Gross dividend payment | ||||||||||
Basic earnings per share | -11.48%77.29 | 3.90%83.31 | 8.66%88.58 | 8.92%271.69 | 3.47%22.68 | 10.88%87.31 | 1.67%80.18 | 16.56%81.52 | 30.77%249.45 | 11,636.84%21.92 |
Diluted earnings per share | -11.47%77.28 | 3.90%83.29 | 8.69%88.57 | 8.93%271.63 | 3.51%22.68 | 10.90%87.29 | 1.69%80.16 | 16.56%81.49 | 30.77%249.36 | 11,631.58%21.91 |
Dividend per share | 0 | 3.19%97 | 0 | 3.19%194 | -11.50%100 | 0 | 25.33%94 | 0 | 34.29%188 | 50.67%113 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |